Autoimmune pancreatitis is a distinct form of pancreatitis characterized clinically by frequent presentation with obstructive jaundice with or without a pancreatic mass, histologically by a lymphoplasmacytic infiltrate and fibrosis and therapeutically by a dramatic response to steroids. Continue reading “International Consensus Diagnostic Criteria for Autoimmune Pancreatitis (AIP)”
Chapel Hill Consensus Conference (CHCC) is a nomenclature system (nosology). It is neither a classification system that specifies what findings must be observed in a specific patient to classify that patient for clinical research nor a diagnostic system that directs clinical management. Continue reading “2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides”
This International Myeloma Working Group consensus updates the disease definition of multiple myeloma to include validated biomarkers in addition to existing requirements of attributable CRAB features (hypercalcaemia, renal failure, anaemia, and bone lesions).
Continue reading “Revised IMWG Diagnostic Criteria for Multiple Myeloma”
The International Classification of Retinopathy of Prematurity (ICROP) was published in 2 parts, the first in 1984 and later expanded in 1987. It was a consensus statement of an international group of retinopathy of prematurity experts.
Continue reading “International Classification of Retinopathy of Prematurity”
I. Ocular symptoms: a positive response to at least one of the following questions:
Have you had daily, persistent, troublesome dry eyes for more than 3 months?
Do you have a recurrent sensation of sand or gravel in the eyes?
Do you use tear substitutes more than 3 times a day?
Continue reading “Revised International Classification Criteria for Sjögren’s Syndrome (SS)”
The levels in this new diabetic retinopathy disease severity scale consist of five scales with increasing risks of retinopathy.
Continue reading “International Clinical Diabetic Retinopathy and Diabetic Macular Edema Disease Severity Scales”
The Tumor, Node, Metastasis (TNM) staging system for lung cancer is an internationally accepted system used to characterize the extent of disease. The TNM system combines features of the tumor into disease stage groups that correlate with survival and are linked to recommendations for treatment.
Continue reading “Tumor, Node, Metastasis International Staging System for Lung Cancer”